Donepezil vs Tofacitinib

Donepezil vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Donepezil and Tofacitinib.

Mechanism of Action

Donepezil: Reversible acetylcholinesterase inhibitor.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Donepezil — 70 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Donepezil — C24H29NO3; Tofacitinib — C16H20N6O.

Molecular Weight: Donepezil — 379.4920 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Donepezil — Small molecule; Tofacitinib — Small molecule.